A New Algorithm for Integrated Analysis of miRNA-mRNA Interactions Based on Individual Classification Reveals Insights into Bladder Cancer

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Hecker, Nikolai ^a,b   Stephan, Carsten ^b,c   Mollenkopf, Hans Joachim ^d   Jung, Klaus ^b,c   Preissner, Robert ^b   Meyer, Hellmuth A ^b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Berlin Institute for Urologic Research   (Germany)

^d MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER MUCOSA; CANCER GENETICS; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CLASSIFICATION ALGORITHM; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MALE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; NUCLEOTIDE SEQUENCE; PREDICTION; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; TUMOR INVASION; UPREGULATION; ALGORITHM; BIOLOGY; BLADDER TUMOR; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; SIGNAL TRANSDUCTION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; URINARY BLADDER NEOPLASMS;

EID: 84878150786     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064543     Document Type: Article

References (75)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Messing EM (2002) Urothelial tumors of the urinary tract. Campbell's Urology. 8 ed. Philadelphia: Saunders. 2732-2784.
3. McConkey DJ, Lee S, Choi W, Tran M, Majewski T, et al. (2010) Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression. Urol Oncol 28: 429-440.
4. Hernandez S, de Muga S, Agell L, Juanpere N, Esgueva R, et al. (2009) FGFR3 mutations in prostate cancer: association with low-grade tumors. Mod Pathol 22: 848-856.
5. Miyao N, Tsai YC, Lerner SP, Olumi AF, Spruck CH, 3rd, et al (1993) Role of chromosome 9 in human bladder cancer. Cancer Res 53: 4066-4070.
6. Puzio-Kuter AM, Castillo-Martin M, Kinkade CW, Wang X, Shen TH, et al. (2009) Inactivation of p53 and Pten promotes invasive bladder cancer. Genes Dev 23: 675-680.
7. Catto JW, Miah S, Owen HC, Bryant H, Myers K, et al. (2009) Distinct microRNA alterations characterize high- and low-grade bladder cancer. Cancer Res 69: 8472-8481.
8. Dyrskjot L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, et al. (2009) Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res 69: 4851-4860.
9. Mengual L, Burset M, Ribal MJ, Ars E, Marin-Aguilera M, et al. (2010) Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma. Clin Cancer Res 16: 2624-2633.
10. Zaravinos A, Lambrou GI, Boulalas I, Delakas D, Spandidos DA, (2011) Identification of common differentially expressed genes in urinary bladder cancer. PLoS One 6: e18135.
11. Li X, Chen J, Hu X, Huang Y, Li Z, et al. (2011) Comparative mRNA and microRNA expression profiling of three genitourinary cancers reveals common hallmarks and cancer-specific molecular events. PLoS One 6: e22570.
12. Fendler A, Stephan C, Yousef GM, Jung K, (2011) MicroRNAs as regulators of signal transduction in urological tumors. Clin Chem 57: 954-968.
13. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
14. Nam D, Kim SY, (2008) Gene-set approach for expression pattern analysis. Brief Bioinform 9: 189-197.
15. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
16. Markina MS, Lubnin A, Korshunov AG, Kozlov AV (2007) [Venous thromboembolic events in neurosurgical patients. Part I. Analysis of their incidence on the basis of autopsy material]. Zh Vopr Neirokhir Im N N Burdenko: 36-39; discussion 39.
17. Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z, (2009) GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics 10: 48.
18. Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A, (2012) GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res 40: W478-483.
19. Zheng Q, Wang XJ, (2008) GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis. Nucleic Acids Res 36: W358-363.
20. Huang da W, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
21. Witkos TM, Koscianska E, Krzyzosiak WJ, (2011) Practical Aspects of microRNA Target Prediction. Curr Mol Med 11: 93-109.
22. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
23. Friedman R, Farh KK-H, Burge C, Bartel D, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Research 19: 92-105.
24. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105.
25. Garcia DM, Baek D, Shin C, Bell GW, Grimson A, et al. (2011) Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol 18: 1139-1146.
26. Grun D, Wang YL, Langenberger D, Gunsalus KC, Rajewsky N, (2005) microRNA target predictions across seven Drosophila species and comparison to mammalian targets. PLoS Comput Biol 1: e13.
27. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500.
28. Lall S, Grun D, Krek A, Chen K, Wang YL, et al. (2006) A genome-wide map of conserved microRNA targets in C. elegans. Curr Biol 16: 460-471.
29. Chen K, Rajewsky N, (2006) Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet 38: 1452-1456.
30. Enright AJ, John B, Gaul U, Tuschl T, Sander C, et al. (2003) MicroRNA targets in Drosophila. Genome Biol 5: R1.
31. John B, Enright AJ, Aravin A, Tuschl T, Sander C, et al. (2004) Human MicroRNA targets. PLoS Biol 2: e363.
32. Betel D, Koppal A, Agius P, Sander C, Leslie C, (2010) Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 11: R90.
33. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E, (2007) The role of site accessibility in microRNA target recognition. Nat Genet 39: 1278-1284.
34. Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G, Maragkakis M, et al. (2012) TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res 40: D222-229.
35. Xiao F, Zuo Z, Cai G, Kang S, Gao X, et al. (2009) miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 37: D105-110.
36. Alexiou P, Vergoulis T, Gleditzsch M, Prekas G, Dalamagas T, et al. (2010) miRGen 2.0: a database of microRNA genomic information and regulation. Nucleic Acids Res 38: D137-141.
37. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ, (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140-144.
38. Cho S, Jun Y, Lee S, Choi HS, Jung S, et al. (2011) miRGator v2.0: an integrated system for functional investigation of microRNAs. Nucleic Acids Res 39: D158-162.
39. Yang JH, Li JH, Shao P, Zhou H, Chen YQ, et al. (2011) starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res 39: D202-209.
40. Anders G, Mackowiak SD, Jens M, Maaskola J, Kuntzagk A, et al. (2012) doRiNA: a database of RNA interactions in post-transcriptional regulation. Nucleic Acids Res 40: D180-186.
41. Sood P, Krek A, Zavolan M, Macino G, Rajewsky N, (2006) Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci U S A 103: 2746-2751.
42. van Dongen S, Abreu-Goodger C, Enright AJ, (2008) Detecting microRNA binding and siRNA off-target effects from expression data. Nat Methods 5: 1023-1025.
43. Alexiou P, Maragkakis M, Papadopoulos GL, Simmosis VA, Zhang L, et al. (2010) The DIANA-mirExTra web server: from gene expression data to microRNA function. PLoS One 5: e9171.
44. Creighton CJ, Nagaraja AK, Hanash SM, Matzuk MM, Gunaratne PH, (2008) A bioinformatics tool for linking gene expression profiling results with public databases of microRNA target predictions. RNA 14: 2290-2296.
45. Sales G, Coppe A, Bisognin A, Biasiolo M, Bortoluzzi S, et al. (2010) MAGIA, a web-based tool for miRNA and Genes Integrated Analysis. Nucleic Acids Res 38: W352-359.
46. Bisognin A, Sales G, Coppe A, Bortoluzzi S, Romualdi C, (2012) MAGIA(2): from miRNA and genes expression data integrative analysis to microRNA-transcription factor mixed regulatory circuits (2012 update). Nucleic Acids Res 40: W13-21.
47. Nam S, Li M, Choi K, Balch C, Kim S, et al. (2009) MicroRNA and mRNA integrated analysis (MMIA): a web tool for examining biological functions of microRNA expression. Nucleic Acids Res 37: W356-362.
48. Liang Z, Zhou H, He Z, Zheng H, Wu J, (2011) mirAct: a web tool for evaluating microRNA activity based on gene expression data. Nucleic Acids Res 39: W139-144.
49. Huang GT, Athanassiou C, Benos PV, (2011) mirConnX: condition-specific mRNA-microRNA network integrator. Nucleic Acids Res 39: W416-423.
50. Laczny C, Leidinger P, Haas J, Ludwig N, Backes C, et al. (2012) miRTrail-a comprehensive webserver for analyzing gene and miRNA patterns to enhance the understanding of regulatory mechanisms in diseases. BMC Bioinformatics 13: 36.
51. Huang JC, Babak T, Corson TW, Chua G, Khan S, et al. (2007) Using expression profiling data to identify human microRNA targets. Nat Methods 4: 1045-1049.
52. Huang JC, Morris QD, Frey BJ, (2007) Bayesian inference of MicroRNA targets from sequence and expression data. J Comput Biol 14: 550-563.
53. Gennarino VA, Sardiello M, Avellino R, Meola N, Maselli V, et al. (2009) MicroRNA target prediction by expression analysis of host genes. Genome Res 19: 481-490.
54. Li X, Gill R, Cooper NG, Yoo JK, Datta S, (2011) Modeling microRNA-mRNA interactions using PLS regression in human colon cancer. BMC Med Genomics 4: 44.
55. Muniategui A, Nogales-Cadenas R, Vazquez M, Aranguren XL, Agirre X, et al. (2012) Quantification of miRNA-mRNA interactions. PLoS One 7: e30766.
56. Jayaswal V, Lutherborrow M, Ma DD, Yang YH, (2011) Identification of microRNA-mRNA modules using microarray data. BMC Genomics 12: 138.
57. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
58. Tibshirani R, Hastie T, Narasimhan B, Chu G, (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 99: 6567-6572.
59. Ratert N, Meyer HA, Jung M, Mollenkopf HJ, Wagner I, et al. (2012) Reference miRNAs for miRNAome Analysis of Urothelial Carcinomas. PLoS One 7: e39309.
60. Sobin LH, Wittekind C (2002) TNM Classification of Malignant Tumours (UICC) New York: Wiley-Liss. 199 p.
61. Jung M, Mollenkopf HJ, Grimm C, Wagner I, Albrecht M, et al. (2009) MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy. J Cell Mol Med 13: 3918-3928.
62. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG, (2009) The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res 37: D155-158.
63. Betel D, Wilson M, Gabow A, Marks DS, Sander C, (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36: D149-153.
64. Halkidi M, Batistakis Y, Vazirgiannis M, (2001) On Clustering Validation Techniques. Journal of Intelligent Information Systems 17: 107-145.
65. Jaccard P, (1912) The Distribution of the Flora in the Alpine Zone. New Phytologist 11: 37-50.
66. Struyf A, Hubert M, Rousseeuw PJ, (1997) Integrating robust clustering techniques in S-PLUS. Computational Statistics & Data Analysis 26: 17-37.
67. Venables WN, Ripley BD (2002) Modern Applied Statistics with S: Springer-Verlag.
68. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M, (2012) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 40: D109-114.
69. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
70. Sobti RC, MalekZadeh K, Nikbakht M, Sadeghi IA, Shekari M, et al. (2010) Hypermethylation-mediated partial transcriptional silencing of DAP-kinase gene in bladder cancer. Biomarkers 15: 167-174.
71. Christoph F, Hinz S, Kempkensteffen C, Weikert S, Krause H, et al. (2007) A gene expression profile of tumor suppressor genes commonly methylated in bladder cancer. J Cancer Res Clin Oncol 133: 343-349.
72. Dyrskjot L, Kruhoffer M, Thykjaer T, Marcussen N, Jensen JL, et al. (2004) Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 64: 4040-4048.
73. Varga A, Czifra G, Tallai B, Nemeth T, Kovacs I, et al. (2004) Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas. Eur Urol 46: 462-465.
74. Langzam L, Koren R, Gal R, Kugel V, Paz A, et al. (2001) Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy. Am J Clin Pathol 116: 377-385.
75. Feber A, Clark J, Goodwin G, Dodson AR, Smith PH, et al. (2004) Amplification and overexpression of E2F3 in human bladder cancer. Oncogene 23: 1627-1630.